[Constipation in infants: influence of type of feeding and dietary fiber intake]

Andrea Nogueira de Campos Aguirre1, Márcia Regina Vítolo, Rosana Fiorini Puccini

  • 1Nutrição, Universidade Federal de São Paulo, SP. andrea.aguirre@utp.br

Jornal De Pediatria
|December 4, 2003
PubMed

Insights

Breast-feeding protects infants from constipation, while artificial feeding increases risk. Dietary fiber intake did not significantly differ between constipated and non-constipated infants in this study.

Area of Science:

  • Pediatrics
  • Nutrition Science
  • Gastroenterology

Context:

  • Infant constipation is a common concern in primary care settings.
  • Feeding practices, including breast-feeding and artificial feeding, are potential factors influencing infant bowel habits.
  • Dietary fiber intake is often considered a key element in managing constipation.

Purpose:

  • To investigate the association between breast-feeding, dietary fiber intake, and constipation in infants.
  • To compare constipation prevalence across different infant feeding patterns.
  • To determine the role of dietary fiber in infant constipation.

Summary:

  • Constipation affected 25.1% of the 275 infants studied, with higher prevalence in infants aged 6-24 months compared to those under 6 months.
  • Infants on artificial feeding were 4.53 times more likely to develop constipation than predominantly breastfed infants.
  • No significant difference in daily dietary fiber intake was observed between constipated and non-constipated infants.

Impact:

  • Breast-feeding is identified as a protective factor against constipation in infants, particularly within the first six months of life.
  • Findings suggest that focusing on breast-feeding support may be crucial for preventing infant constipation.
  • The study highlights that dietary fiber intake alone may not be the primary determinant of constipation in this infant population.
Abstract

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Anatomy of the Intestines01:53

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.Small IntestinesThe small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small intestine...
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...